Early Alert: Nitric Oxide Delivery System Issue from NOxBOX

RegulatoryNOxBOXi SystemNegative

AI Analysis

Summary

FDA issued an early alert regarding the NOxBOXi System for potential oxygen leakage during inhaled nitric oxide therapy. The device manufacturer has been notified of the safety concern.

Outcome Details

Early alert issued for potential oxygen leakage during inhaled nitric oxide therapy

Importance:7/10

Sentiment:

-0.80

safety alertdevice issueFDA MedWatchnitric oxide therapyproduct defect

Read the original article

Published by FDA MedWatch Safety Alerts on August 24, 2026 4:00 AM

Read Original